PF-Atlas › Clinical Trials › NCT04461587

Examination of Pirfenidone Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis

Pirfenidone · Phase 2

Registry ID
NCT04461587
Phase
Phase 2
Status
Completed
Drug / intervention
Pirfenidone
Sponsor
Pulmonary Research of Abingdon, LLC
Start
2020-08-31

About this trial

Pirfenidone is evaluated in NCT04461587, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Pulmonary Research of Abingdon, LLC. Current status: Completed.

View NCT04461587 on ClinicalTrials.gov →

Explore related

All Pirfenidone trialsAll IPF trials

Related trials

Pirfenidone — NCT00001959pirfenidone — NCT00662038Pirfenidone — NCT02951429Pirfenidone — NCT00287729Pirfenidone — NCT01504334Pirfenidone — NCT02932566
Medical disclaimer. This page summarizes public trial data for NCT04461587 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.